The globalretinal disorder treatment marketis anticipated to grow at a CAGR of 11.2% during the forecast period (2023-2030). Retinal disorders have both high prevalence and incidence in the geria...
Rznomics, a biopharmaceutical company, has developed a groundbreaking 'self-circularized RNA structure' platform technology that efficiently generates circular RNA, overcoming the limitations of ...
